mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.
Saved in:
| Title: | mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer. |
|---|---|
| Authors: | von Wichert L; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Stroh A; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Witt M; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Wanzel M; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany., Mernberger M; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany., Griewing S; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Wündisch T; Comprehensive Cancer Center Marburg, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Pfitzner BM; Institute of Pathology, DRK Clinics Westend, Berlin, Germany., Teply-Szymanski J; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Litmeyer AS; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Denkert C; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Wagner U; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany., Stiewe T; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Genomics Core Facility, Philipps-University, Marburg, Germany.; Institute of Lung Health, Justus Liebig University, Gießen, Germany., Gremke N; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Feb 19; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41714320 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<superscript>+</superscript>/HER2<superscript>-</superscript> breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22von+Wichert+L%22">von Wichert L</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Stroh+A%22">Stroh A</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Witt+M%22">Witt M</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wanzel+M%22">Wanzel M</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Mernberger+M%22">Mernberger M</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Griewing+S%22">Griewing S</searchLink>; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wündisch+T%22">Wündisch T</searchLink>; Comprehensive Cancer Center Marburg, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Pfitzner+BM%22">Pfitzner BM</searchLink>; Institute of Pathology, DRK Clinics Westend, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Teply-Szymanski+J%22">Teply-Szymanski J</searchLink>; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Litmeyer+AS%22">Litmeyer AS</searchLink>; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Denkert+C%22">Denkert C</searchLink>; Institute of Pathology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wagner+U%22">Wagner U</searchLink>; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Stiewe+T%22">Stiewe T</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.; Genomics Core Facility, Philipps-University, Marburg, Germany.; Institute of Lung Health, Justus Liebig University, Gießen, Germany.<br /><searchLink fieldCode="AU" term="%22Gremke+N%22">Gremke N</searchLink>; Institute of Molecular Oncology, Universities of Gießen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de.; Department of Gynecology, Gynecological Endocrinology and Oncology, University Hospital Marburg (UKGM), Philipps-University, Marburg, Germany. Gremken@staff.uni-marburg.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 Feb 19; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Feb 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41714320 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41419-026-08496-5 Languages: – Code: eng Text: English Titles: – TitleFull: mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: von Wichert L – PersonEntity: Name: NameFull: Stroh A – PersonEntity: Name: NameFull: Witt M – PersonEntity: Name: NameFull: Wanzel M – PersonEntity: Name: NameFull: Mernberger M – PersonEntity: Name: NameFull: Griewing S – PersonEntity: Name: NameFull: Wündisch T – PersonEntity: Name: NameFull: Pfitzner BM – PersonEntity: Name: NameFull: Teply-Szymanski J – PersonEntity: Name: NameFull: Litmeyer AS – PersonEntity: Name: NameFull: Denkert C – PersonEntity: Name: NameFull: Wagner U – PersonEntity: Name: NameFull: Stiewe T – PersonEntity: Name: NameFull: Gremke N IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 02 Text: 2026 Feb 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-4889 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Cell death & disease Type: main |
| ResultId | 1 |